Press Releases

Purespring Therapeutics presents preclinical data at the 61st ERA Congress

Data establishes the potential of AAV gene therapy to deliver transgenes to the podocyte to replace defective genes or to modulate protein production

Data underpin the potential of AAV as an important novel modality to treat a broad range of kidney disease

London— 24 May 2024— Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney... (continue reading...)

The Industrial and Institutional Cleaning Chemicals Market is experiencing significant growth, driven by the increasing awareness of hygiene and sanitation practices across various sectors. According to a report by SNS Insider, the market, valued at USD 75.02 billion in 2023, is projected to reach USD 137.54 billion by 2031, with a CAGR of 7.9% during the forecast period of 2024-2031.

The heightened awareness among individuals and the precautions taken to mitigate the... (continue reading...)

The Digital Clinical Trials Market, valued at USD 8.70 Billion in 2023, is anticipated to reach a valuation of USD 13.86 Billion by 2031. This translates to a compound annual growth rate (CAGR) of 6% throughout the forecast period from 2024 to 2031.

List of Digital Clinical Trials Companies Profiled in Report:

• PPD
• Signant Health
• PRA Health Sciences
• Parexel International Corporation
• Oracle
• Medidata
• Medable, Inc.
• LEO Innovation Lab
• IQVIA
• ICON, plc
• IBM
• Human first
• Halo... (continue reading...)

The SNS Insider report reveals that the concrete floor coating market was valued at USD 4.75 billion in 2023 and is expected to reach USD 7.21 billion by 2031, demonstrating a CAGR of 5.5% from 2024-2031.

The construction industrys growth, coupled with the rising use of coatings in these diverse sectors, fueling the concrete floor coating markets expansion.

The expansion of the construction industry, coupled with the growing utilization of coatings in industrial,... (continue reading...)

The Hemophilia Market was valued at USD 13.6 Billion in 2023 and is anticipated to reach USD 22.50 Billion by 2031. This translates to a remarkable compound annual growth rate (CAGR) of 6.5% throughout the forecast period.

The World Federation of Hemophilia estimates that 386,966 people globally have bleeding disorders, with hemophilia accounting for 233,577 cases. This high prevalence, coupled with increasing government initiatives to improve access to treatment, is... (continue reading...)